ORP2 regulates free cholesterol accumulation in hepatocytes during MASH
Jin WuiD, Yudi Zhao, Liwen Qiu, Qiaoli CheniD, Xiaowei Wang, Jingwen GuiD, Yan LiangiD, Yingjie Zhang, Hongyu Wang, Yang LiuiD, Xiaoqin Wu, Daiwen CheniD, Feng‐Jung CheniD, Mingming GaoiD, Hongyuan YangiD
Abstract
BackgroundCholesterol crystals in hepatocytes are known to strongly associate with human Metabolic Dysfunction-Associated Steatohepatitis (MASH). However, it remains unclear which molecular pathway(s) regulates free cholesterol accumulation, and therefore the formation of cholesterol crystals in hepatocytes. In cultured cell lines, oxysterol-binding protein-related protein 2 (ORP2) functions to deliver cholesterol to the plasma membrane from internal organelles. MethodsHere, we generated liver-specific ORP2 knockout (ORP2-LKO) mice and characterized their metabolic phenotypes on chow and high fat diet. ResultsThe ORP2-LKO mice developed much more severe hepatic steatosis than wild type mice after high-fat diet feeding. They also demonstrated more severe liver inflammation and damage. Notably, free but not esterified cholesterol, as well as cholesterol crystals accumulated in ORP2-LKO liver. The expression of Cyp7a1 was significantly upregulated in ORP2-LKO liver, accompanied with accumulation of taurocholic acid. Our results thus unveil an important in vivo function of ORP2 in preventing free cholesterol from accumulating in mouse liver. Conclusionsour results suggest that impaired cholesterol trafficking may enhance the deposition of cholesterol crystals in hepatocytes, promoting the development of MASH.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 1.22
- Field percentile
- top 21%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sterol O-acyltransferase (SOAT/ACAT) activity is required to form cholesterol crystals in hepatocyte lipid droplets
Jordan A. Bairos, Uche Chinedu Njoku, … Scott B. Widenmaier·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of LipidsPeer-reviewed·May 16, 2024
- Monounsaturated fat prevent, whereas saturated fat promote, cholesterol crystals in cytoplasmic lipid droplets
Uche Njoku, Sierra Siedlecki, … Scott B. Widenmaier·bioRxiv·Nov 3, 2026
- Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis
Ikki Sakuma, Rafael Calais Gaspar, … Gerald I. Shulman·Proceedings of the National Academy of SciencesPeer-reviewed·May 1, 2025
- Hepatocyte Circadian Clocks Control Cholesterol Metabolism and Protect From Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Leonardo Vinícius Monteiro de Assis, Lina Jegodzinski, … Henrik Oster·Cellular and Molecular Gastroenterology and HepatologyPeer-reviewed·Jan 1, 2026
- Intrahepatic crystals from elevated dietary cholesterol are sufficient to stiffen the liver
David Li, Abigail E. Loneker, … Rebecca G. Wells·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 7, 2026
- Hepatocyte-, but not myeloid cell-Rictor/mTORC2 deficiency moderately attenuates steatotic liver disease induced by intake of a choline-deficient, amino acid-defined high-fat diet
Bianca Franco Leonardi, Ana B. Pires, … William T. Festuccia·bioRxiv·Jun 18, 2026